EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access · CC BY 4.0

Ketamine in multiple treatment-resistant depressed inpatients: A naturalistic cohort study

Stefan Vestring, Viktoria Galuba, Elisa Kern, Sabine Voita, Franziska Berens, Danial Nasiri, Katharina Domschke, Claus Normann

Journal of Affective Disorders · 2024-04 · 350 · 895-899

DOI: 10.1016/j.jad.2024.01.165 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Affective Disorders, 2024-04. Verfasst von Stefan Vestring und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; …. Hauptthemen laut MEDLINE: Depressive Disorder, Treatment-Resistant, Ketamine. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medizinische Fakultät der Albert-Ludwigs-Universität Freiburg, Hans Böckler Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ketamine has emerged as an effective treatment option for patients with treatment-resistant depression. However, there is limited evidence of the benefits of ketamine in inpatients with multiple treatment resistance (MTR), who far exceed the formal criteria for treatment resistance and suffer from extensive psychiatric comorbidities. OBJECTIVE: The aim of this naturalistic study was to provide preliminary evidence for the use of ketamine in the treatment of MTR depression in a naturalistic inpatient setting. METHODS: Seventy-seven patients (mean age 45.1 ± 13.8 years) were treated with intravenous or intranasal ketamine (1068 administrations) twice weekly for five weeks, followed by maintenance therapy if clinically indicated. Treatment effects were assessed with the BDI, and side effects were assessed by clinicians. We analyzed dose- and route of application-related changes in depression severity, response and remission rates as well as effects on suicidality and frequency of adverse events. RESULTS: Depression severity and suicidality decreased in the acute treatment phase and these changes persisted during the maintenance therapy phase. A total of 28.9 % of the patients met the criteria for response, and 15 % met the criteria for remission. The initial treatment response was highly predictive of the outcome at the end of the acute treatment phase. None of the reported side effects required medical intervention. High-dose intravenous ketamine (0.75-1 mg/kg) resulted in the most pronounced clinical effects. LIMITATIONS: This observational, retrospective, and naturalistic study may be subject to bias and did not allow control of external variables. CONCLUSIONS: We outlined a clinically feasible, high-dose ketamine treatment regimen for hospitalized patients with MTR depression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Depressive Disorder, Treatment-ResistantKetamineAdultHumansMiddle AgedAntidepressive AgentsCohort StudiesInpatientsRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

DepressionKetamineKetamine treatment regimenMultiple treatment resistanceNaturalistic settingRapid-acting antidepressants

Substanzen

Antidepressive AgentsKetamine

Autor:innen und Institutionen

  • Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Berta-Ottenstein-Programme for Clinician Scientists, Faculty of Medici…
  • Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Neuromodulation, Department of Psychiatry and Psychotherapy…

Förderung

  • Medizinische Fakultät der Albert-Ludwigs-Universität Freiburg
  • Hans Böckler Stiftung

Zitieren

APA

Vestring, S., Galuba, V., Kern, E., Voita, S., Berens, F., Nasiri, D., Domschke, K., & Normann, C. (2024). Ketamine in multiple treatment-resistant depressed inpatients: A naturalistic cohort study. Journal of Affective Disorders, 350, 895-899. https://doi.org/10.1016/j.jad.2024.01.165

Vancouver

Vestring S, Galuba V, Kern E, Voita S, Berens F, Nasiri D, et al. Ketamine in multiple treatment-resistant depressed inpatients: A naturalistic cohort study. Journal of Affective Disorders. 2024;350:895-899. doi:10.1016/j.jad.2024.01.165

BibTeX
@article{Vestring2024,
  author = {Vestring, Stefan and Galuba, Viktoria and Kern, Elisa and Voita, Sabine and Berens, Franziska and Nasiri, Danial and Domschke, Katharina and Normann, Claus},
  title = {Ketamine in multiple treatment-resistant depressed inpatients: A naturalistic cohort study},
  journal = {Journal of Affective Disorders},
  year = {2024},
  volume = {350},
  pages = {895--899},
  doi = {10.1016/j.jad.2024.01.165}
}
Kostenlos starten →